-

Three of Asset Value Investors’ Shareholder Proposals Pass at NCHD’s AGM With Another Three Achieving Majority Shareholder Support

LONDON--(BUSINESS WIRE)--Asset Value Investors Limited (“AVI”) submitted eight shareholder proposals to NC Holdings (TSE: 6236, “NCHD”) in the best interests of shareholders. At the ordinary general meeting of shareholders (29 June), three proposals passed while a further three achieved majority shareholder support.

Proposals that passed:

  • A special resolution requiring over two-thirds of the vote, amending the articles of incorporation to give shareholders the authority to determine dividends at general meetings,
  • A dividend of JPY 65 per share, equivalent to a 70% pay-out ratio, and
  • A stock compensation plan for directors, including a stock plan for executive directors based on achieving a three-year total share price return of over 50% and an average three-year ROIC of over 10%.

Proposals which achieved majority shareholder support but did not pass:

  • A special resolution to amend the articles of incorporation to increase the maximum number of directors allowed on the Board from 12 to 13,
  • A special resolution setting minimum requirements when adopting or triggering a poison pill, and
  • A special resolution that requires prior approval by a general meeting of shareholders for a third-party allocation of shares.

AVI believes that the special resolution is one of only a handful of shareholder-proposed special resolutions to have ever passed in Japan and that AVI is one of only three shareholders who had their resolutions successfully passed despite opposition by the Company this June AGM season.

That the Board of Directors opposed six shareholder resolutions supported by a majority of shareholders raises serious questions as to whether the current directors are acting in shareholders’ best interests.

AVI views the approval of three shareholder proposals and the majority support for three more as a significant step forward in enhancing NCHD’s corporate value in the best interests of NCHD’s shareholders. It is, however, disappointing that the majority-of-the-minority disclosure policy and the Board’s attempt to intimidate shareholders hindered dialogue between AVI and other shareholders, preventing an open and honest debate.

NCHD’s corporate value continues to be 60% below its peers. AVI will strengthen its engagement with NCHD over the coming year and consider all options to ensure the Board of Directors is acting in the best interests of shareholders. The full press release can be found at the following link: https://www.assetvalueinvestors.com/content/uploads/2023/07/AVI-Press-Release-NCHD-AGM-Results.pdf and AVI’s campaign website at: www.enhancingNCHD.com

-Ends-

Contacts

Asset Value Investors Limited
Kaz Sakai
kaz.sakai@assetvalueinvestors.com

Asset Value Investors



Contacts

Asset Value Investors Limited
Kaz Sakai
kaz.sakai@assetvalueinvestors.com

More News From Asset Value Investors

AVI Calls for Changes at Gerresheimer

LONDON--(BUSINESS WIRE)--Asset Value Investors (“AVI”) has sent an open letter to the Supervisory Board of Gerresheimer AG (“Gerresheimer”) calling for it to make changes to its financial leadership. You can find the published letter here. AVI invested in Gerresheimer in 2024 and manages a 3.5% stake on behalf of institutional clients. Gerresheimer holds a valuable position in the Containment Solutions & Delivery Systems industry, with high barriers to entry and attractive long-term growth...

AVI Urges Wacom To Make Governance Changes

LONDON--(BUSINESS WIRE)--Asset Value Investors Limited (“AVI”) launches a campaign calling for Wacom Corporation (“Wacom”) to be more conscious of the capital market, and announces that AVI has submitted shareholder proposals ahead of Wacom’s upcoming AGM in June. AVI has published a detailed presentation on a dedicated website. AVI invested in Wacom in August 2021 and has sought to engage in dialogue with the company as the largest shareholder, sending letters and presentations with the aim of...

Asset Value Investors Urges Rohto Pharmaceutical to Focus on Core Businesses and Engage With Shareholders More Constructively

LONDON--(BUSINESS WIRE)--Asset Value Investors Limited (‘AVI’) launches a campaign calling for Rohto Pharmaceutical (‘Rohto’) to focus on its core businesses rather than allocating resources to the unsuccessful regenerative medicine business, and to engage with shareholders more constructively to comply with the Tokyo Stock Exchange’s (‘TSE’) request for management that is conscious of the cost of capital and stock price. A detailed presentation can be found here. Since AVI started investing in...
Back to Newsroom